AGC Biologics and Horizon Therapeutics plc expand partnership


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ AGC Biologics and Horizon Therapeutics plc expand partnership
The collaboration offers to customers in need of high volume commercial production

AGC Biologics, a leading global biopharmaceutical contract development and manufacturing organization (CDMO), announced that its partnership with Horizon Therapeutics plc is expanding to produce the treatment Thyroid Eye Disease (TED) Clinic, TEPEZZA, at AGC's new facility in Boulder, CO. The state-of-the-art facility includes two 20,000L stainless steel mammalian bioreactors that AGC offers to customers in need of high volume commercial production.

"We have partnered with AGC on TEPEZZA production for over three years and have seen excellent collaboration between our technical teams, which has resulted in rapid process transfer and efficient launch," said Michael DesJardin, Executive Vice President, technical operations and corporate quality, Horizon. "AGC has a deep understanding of TEPEZZA and we look forward to expanding our partnership."

AGC and Horizon began partnering in 2017 and there are ongoing projects at AGC's facilities in Copenhagen and Seattle. Horizon will now be AGC's first customer to have a product manufactured at the new site in Boulder. The facility is well equipped for the production of TEPEZZA. Following approval, the facility is expected to produce the majority of TEPEZZA's supply.

"We are excited to expand our strategic partnership with Horizon by leveraging large-scale stainless steel capacity at our new facility in Boulder, " said Mark Womack, Business Director for AGC Biologics. "Our globally aligned network is equipped and ready to continue supplying TEPEZZA to the market."

Tags : #AGCBiologics #LatestNewsonAGCBiologics30thOct #HorizonTherapeutics #LatestNewsonHorizonTherapeutics30thOct #LatestPharmaNews30thOct #LatestPharmaCollaboration30thOct #MichaelDesJardin #MarkWomack

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026